Chaplain Peter Jupin, Executive Director of Oncology Nikolas Buescher, Medical Director of Oncology Dr. Randall Oyer and Nurse Navigator Amy Jo Pixley / Cancer Institute
A team from the Ann B. Barshinger Cancer Institute visited the White House Jan. 11, to attend former President Barack Obama’s weekly “Making Health Care Better” meeting.
That day’s meeting was devoted to former Vice President Joe Biden’s Cancer Moonshot initiative, with a focus on community-based cancer care.
The Cancer Institute team included Medical Director of Oncology Randall A. Oyer, M.D., Executive Director of Oncology Nikolas Buescher, Nurse Navigator Amy Jo Pixley and Chaplain Peter Jupin.
The meeting covered a number of topics, including the impact of health policy on cancer outcomes, support services and survivorship; health disparities in cancer care; clinical trials in the community setting; the challenges of rural providers; and the Oncology Care Model.
The Cancer Institute team was invited to the White House following its participation in the June Cancer Moonshot Summit meeting in Washington, D.C., and the Moonshot team’s August tour of the Cancer Institute.
“People at the national level are listening to what the Cancer Institute has to say and looking at what our teams are accomplishing for cancer patients in our community,” Dr. Oyer said.
LG Health trauma team wins award for preventing hay-hole injuries
LG Health’s trauma team has won the 2017 Cox-Templeton Injury Prevention Paper Competition for its work to prevent hay-hole-related injuries on Amish farms.
The award honors the best prevention project presented at the Eastern Association for Surgery of Trauma’s annual meeting. Fred Rogers, M.D., LG Health Medical Director, Trauma, and Eric H. Bradburn, D.O., attended the meeting, held in January in Fort Lauderdale, Florida.
The LG Health team worked with community partners to design and distribute 231 hay-hole covers, which prevent a common source of serious traumatic injuries on Amish farms.
“Dr. Bradburn presented the results of our work and did a superb job,” Dr. Rogers said. “Needless to say, I was quite proud of our team and was inundated afterwards with congratulations from my trauma colleagues from all over.”
Dr. Jhaveri implants device shown to reduce recurrent ischemic stroke risk
Rahul R. Jhaveri, M.D.
Lancaster General Hospital is the first in Pennsylvania to implant the only FDA-approved device designed to prevent blood clots from entering the brain by sealing a hole in the heart.
Rahul R. Jhaveri, M.D., an interventional cardiologist with The Heart Group of LG Health, implants the AMPLATZER™ PFO Occluder, which helps reduce the risk of recurrent ischemic strokes in patients who have a patent foramen ovale, or small opening between the upper chambers of the heart.
The foramen ovale typically closes shortly after birth but remains open, or “patent,” in about 25 percent of adults. A PFO can potentially allow dangerous clots to pass between the heart chambers and to the brain but is often not detected until a patient has a stroke from an unknown cause.
The AMPLATZER PFO Occluder is designed to seal the hole and reduce this risk.
“This innovative technology allows us reduce the risk of subsequent strokes for patients with a PFO, many of whom never knew they had the condition prior to suffering a stroke,” Dr. Jhaveri said. “We’re fortunate to be able to offer the benefits of this device … to our community.”
Drs. Andersen, Kelly, Oyer featured in local media
Rolf L. Andersen, M.D., of The Heart Group of LG Health, and Lars Andersen of the LG Health Research Institute, wrote an LNP letter to the editor in support of testing for familial hypercholesterolemia. Read more about the Andersens’ FH research here.
LNP covered a Highmark incentive plan that offers primary-care physicians an additional monthly care-coordination payment per patient. James M. Kelly, M.D., of LG Health Physicians Family Medicine Lincoln, told LNP that any funds to help cover extra work for practices are welcome.
In a Sunday op-ed, Randall Oyer, M.D., urged readers to know their family history, ask questions and take a personalized approach to reducing cancer risk.